Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …

BACKGROUND : Hemovigilance networks have been introduced in several countries to
improve knowledge of blood transfusion‐related morbidity and mortality. The general …

Plasma provided by COVID‐19 convalescent patients may provide therapeutic relief as the
number of COVID‐19 cases escalates steeply worldwide. Prior findings in various viral …

Most cases of hepatitis E viral (HEV) infection in developed countries are autochthonous.
Nevertheless, the reported seroprevalence of HEV varies greatly depending on the …

We investigated the distribution of antibodies neutralizing SARS-CoV-2 according to age, sex
or blood group in French blood donors. In 464 samples collected before the emergence of …

Patients with hematological malignancy and COVID-19 display a high mortality rate. In such
patients, immunosuppression due to underlying disease and previous specific treatments …

The risk of transfusion-associated transmission of SARS-CoV-2 is unknown. Cappy and
colleagues report on hemovigilance studies of 268 blood donations from individuals reporting …

To evaluate whether a new enzyme immunoassay developed for the simultaneous detection
of hepatitis C virus (HCV) core antigen (Ag) and anti-HCV antibodies (anti-HCV Ab) (…